Millennium Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-812,262
| Closed | -$3.75M | – | 4740 |
|
|
2019
Q1 | $3.75M | Buy |
812,262
+266,775
| +49% | +$1.26M | 0.01% | 1957 |
|
|
2018
Q4 | $1.91M | Buy |
545,487
+256,474
| +89% | +$1.78M | ﹤0.01% | 2210 |
|
|
2018
Q3 | $2.91M | Buy |
289,013
+118,909
| +70% | +$949K | ﹤0.01% | 2164 |
|
|
2018
Q2 | $1.23M | Buy |
+170,104
| New | +$1.19M | ﹤0.01% | 2703 |
|
|
2018
Q1 | – | Sell |
-12,733
| Closed | -$122K | – | 4297 |
|
|
2017
Q4 | $122K | Sell |
12,733
-4,043
| -24% | -$26.5K | ﹤0.01% | 3631 |
|
|
2017
Q3 | $149K | Buy |
+16,776
| New | +$173K | ﹤0.01% | 3314 |
|
|
2017
Q2 | – | Sell |
-217,385
| Closed | -$2.29M | – | 4078 |
|
|
2017
Q1 | $2.29M | Sell |
217,385
-119,832
| -36% | -$1.28M | ﹤0.01% | 1930 |
|
|
2016
Q4 | $3.1M | Buy |
337,217
+115,012
| +52% | +$1.3M | 0.01% | 1636 |
|
|
2016
Q3 | $2.62M | Sell |
222,205
-74,023
| -25% | -$1.13M | ﹤0.01% | 1766 |
|
|
2016
Q2 | $3.83M | Buy |
296,228
+180,676
| +156% | +$2.63M | 0.01% | 1416 |
|
|
2016
Q1 | $1.85M | Buy |
115,552
+5,557
| +5% | +$106K | ﹤0.01% | 1822 |
|
|
2015
Q4 | $3.15M | Buy |
+109,995
| New | +$3.05M | 0.01% | 1650 |
|
|
2015
Q3 | – | Sell |
-45,731
| Closed | -$1.64M | – | 3885 |
|
|
2015
Q2 | $1.64M | Sell |
45,731
-320,143
| -88% | -$9.97M | ﹤0.01% | 2030 |
|
|
2015
Q1 | $10.6M | Sell |
365,874
-876,826
| -71% | -$23.2M | 0.02% | 978 |
|
|
2014
Q4 | $26.2M | Sell |
1,242,700
-303,092
| -20% | -$5.99M | 0.06% | 480 |
|
|
2014
Q3 | $30M | Buy |
1,545,792
+1,317,700
| +578% | +$20.7M | 0.08% | 324 |
|
|
2014
Q2 | $3.56M | Buy |
228,092
+43,734
| +24% | +$707K | 0.01% | 1412 |
|
|
2014
Q1 | $3.82M | Buy |
184,358
+145,610
| +376% | +$2.89M | 0.01% | 1360 |
|
|
2013
Q4 | $500K | Sell |
38,748
-96,081
| -71% | -$1.33M | ﹤0.01% | 2709 |
|
|
2013
Q3 | $1.57M | Buy |
+134,829
| New | +$1.11M | 0.01% | 1835 |
|
Other funds holding INSY
WS
Millennium Management's INSY Position: Q2 2019 in Review
Millennium Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 812,262 shares — an estimated $3.75M sold.
Millennium Management first reported a position in INSY in Q3 2013 and held it in 20 quarters. The position peaked at $30M in Q3 2014. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Millennium Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Millennium Management sold 812,262 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $3.75M.
- Millennium Management first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 20 quarters.
- Millennium Management's Insys Therapeutics, Inc. position peaked at $30M in Q3 2014.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.